Sulfamerazine

CHEMBL438 Phase 4 已批准 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
264.3 g/mol
LogP
0.1
Phase
4

Sulfamerazine is an intermediate-acting sulfonamide antibiotic used in combination with other sulfonamides (trisulfapyrimidines) for the treatment of urinary tract infections, nocardiosis, and other susceptible bacterial infections. Combination sulfonamide therapy reduces the risk of crystalluria by lowering the individual concentration of each sulfonamide while maintaining antibacterial activity. Like all sulfonamides, it inhibits dihydropteroate synthase in susceptible bacteria.

分子量

264.3100 g/mol

LogP

0.10

TPSA

106.00 Ų

Lipinski 五规则

符合

Pharmacokinetics (PK)

Pharmacodynamics (PD)

二维结构

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1

InChI

InChI=1S/C11H12N4O2S/c1-8-6-7-13-11(14-8)15-18(16,17)10-4-2-9(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15)

Molecular Formula

C11H12N4O2S

HBD / HBA

2 / 6

可旋转键数

3

重原子数

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

Sulfamerazine is an intermediate-acting sulfonamide antibiotic used in combination with other sulfonamides (trisulfapyrimidines) for the treatment of urinary tract infections, nocardiosis, and other susceptible bacterial infections. Combination sulfonamide therapy reduces the risk of crystalluria by lowering the individual concentration of each sulfonamide while maintaining antibacterial activity. Like all sulfonamides, it inhibits dihydropteroate synthase in susceptible bacteria.

Yes, Sulfamerazine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL438. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5325. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.